Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10610125 Methods and compositions for cell-proliferation-related disorders

Patent 10610125 was granted and assigned to Agios Pharmaceuticals on April, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Agios Pharmaceuticals

Current Assignee

Agios Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10610125

Date of Patent

April 7, 2020

Patent Application Number

15589615

Date Filed

May 8, 2017

Patent Citations Received

‌

US Patent 11376246 Inhibiting mutant IDH-1

‌

US Patent 11311527 Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)

‌

US Patent 11963956 Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)

‌

US Patent 11576906 Inhibiting mutant IDH-1

‌

US Patent 11013733 Inhibiting mutant isocitrate dehydrogenase 1 (mlDH-1)

‌

US Patent 11013734 Treating patients harboring an isocitrate dehydrogenase-1 (IDH-1) mutation

Patent Primary Examiner

‌

Christopher Adam Hixson

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10610125 Methods and compositions for cell-proliferation-related disorders

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API